Commercial healthcare costs are projected to rise 9% in 2027, the highest medical cost trend in nearly two decades, as health plans cite AI-powered documentation and coding tools…
Behavioral health M&A recorded 42 closed transactions in Q1 2026 — 34 traditional M&A deals and 8 growth financings totaling $535.7 million. Mental health led with 19 deals,…
Dental M&A has rebounded strongly in 2026 after a slowdown driven by elevated capital costs, enhanced due diligence, and unrealistic seller valuations. DSOs are aggressively expanding across specialties…
Physician group private equity deal volume fell from 28% of global provider transactions in 2021 to 23% in 2025, per Bain & Company’s 2026 Global Healthcare Private Equity…
AI in healthcare revenue cycle management has crossed a critical threshold: it is now delivering measurable, repeatable results at enterprise scale. Oliver Wyman’s 2026 Healthcare RCM Survey of…
Sixty-nine percent of DSOs expect their private equity sponsors to push for moderate-to-high increases in acquisition activity in 2026, according to TUSK Practice Sales’ Q2 2026 Dental Market…
Commercial medical cost trend is projected to reach 9% in 2027 — the highest in 17 years — according to PwC’s Behind the Numbers 2027 report. Five inflators…
Behavioral health M&A in 2026 is running slower than expected but deal activity continues. SUD treatment may be the most undervalued subsector, with deal flow at a six-year…
Medicare Advantage (MA) already offers substantially greater price predictability than traditional Medicare — MA enrollees saw monthly out-of-pocket costs 18–24% lower than traditional Medicare from 2014 to 2019,…
Ambulatory surgery center M&A remains active in 2026, with private equity and health systems both accelerating acquisition pace. Tenet Healthcare’s USPI deployed $125 million in Q1 2026 alone…
